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Abstract 
Cognitive impairment (CI) can develop during the course of ageing and is a feature of 
many neurological and neurodegenerative diseases.  Many individuals with CI have 
substantial, sustained and complex healthcare needs which frequently include pain. However, 
individuals with CI can have difficulty communicating the features of their pain to others, 
which in turn presents a significant challenge for effective diagnosis and treatment of their 
pain. Herein, we review the literature on responsivity of individuals with CI to experimental 
pain stimuli. We discuss pain responding across a large number of neurological and 
neurodegenerative disorders in which CI is typically present.  
Overall, the existing data suggest that pain processing is altered in most individuals with 
CI compared to cognitively intact matched controls. The precise nature of these alterations 
varies with the type of CI (or associated clinical condition) and may also depend on the type 
of pain stimulation used and the type of pain responses assessed. Nevertheless, it is clear that 
regardless of the etiology of CI, patients do feel noxious stimuli; with more evidence for 
hypersensitivity than hyposensitivity to these stimuli compared to cognitively unimpaired 
individuals. Our current understanding of the neurobiological mechanisms underpinning these 
alterations is limited, but may be enhanced through the use of animal models of CI which also 
exhibit alterations in nociceptive responding. Further research employing additional 
behavioural indices of pain is warranted. Increased understanding of altered experimental pain 
processing in CI will facilitate the development of improved diagnostic and therapeutic 
approaches for pain in individuals with CI. 
 
Key words: cognitive impairment, experimental pain, dementia, neurodegenerative 
disorders; developmental disorders, pain perception 
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1. Introduction 
Cognitive impairment (CI) refers to deficits or impairment in cognitive function. The term 
may describe deficits in global intellectual performance, but may also refer to deficits in 
specific cognitive domains including memory, language, attention, perception, reasoning and 
executive function. CI can be found in various patient groups, including but not restricted to, 
patients with dementia, individuals with autism, Down syndrome and traumatic brain injury. 
Many individuals with CI have substantial and complex healthcare needs which frequently 
also involve pain. Sources of pain are abundant among these individuals due to neurological 
impairments such as motor disabilities and coordination disorders leading to pathological gait 
and posture, altered muscle tone and general difficulties in activity of daily living. Dislocated 
joints, pressure sores and over-use injuries due to the aforementioned pathologies and to the 
use of assistive devices are additional sources of pain [77,105]. Despite the aforementioned, 
precise estimates on the prevalence of pain among individuals with CI are not abundant. Most 
existing data relate to patients with dementia. Depending on the setting (e.g. nursing homes, 
acute hospitals) the prevalence of pain among patients with dementia may vary from 4 to 
more than 80% [115]. Additional published prevalence rates of pain are 13-75% among 
individuals with developmental disability [121], 40-60% among patients with Parkinson’s 
disease and 12-80% among individuals with traumatic brain injury [17]. Given these 
relatively high prevalence rates, it becomes apparent that pain should be carefully assessed 
and monitored in individuals with CI, in order to provide adequate care.  
Pain is regarded as a multidimensional, complex experience comprised of sensory, 
affective and cognitive aspects that can lead to physiological, emotional and behavioural 
responses. Due to its subjective nature, pain assessment relies mostly on pain self-reporting as 
the “gold standard” and neglects other forms of pain responses. This is despite the fact that 
self-report is only a proxy for subjective experience and reflects more than an exclusive report 
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of pain. Individuals with CI often have difficulties in verbally expressing their pain due to 
poor intellectual and communication capabilities and even if verbal skills are present, they do 
not guarantee valid pain reports. Thus, pain assessment is challenging in individuals with CI 
due to problems in: 1) identifying the presence of pain, 2) diagnosing the source of pain, 3) 
evaluating the magnitude of pain and suffering, 4) deciding on the appropriate treatment and 
following up its effectiveness. It is likely that the difficulties that caregivers as well as of 
healthcare professionals experience in trying to identify painful conditions in individuals  with 
CI, have led to the premise that these individuals may be less sensitive to pain in comparison 
with their cognitively intact peers [1,14,54]. Accordingly, individuals with CI receive 
significantly fewer analgesic medications and healthcare visits compared with cognitively 
intact individuals [2,38,81]. More recent findings indicate that this trend might be slowly 
changing with CI patients even being over-treated with pain medication [56], which might 
lead to different problems (e.g. sedation, heightened fall risk).  Healthcare professionals as 
well as caregivers face the difficulty of knowing whether or not an individual with CI might 
be suffering from pain. Consequently, individuals with CI, especially those with severe CI, 
are still at a high risk of late diagnosis or misdiagnosis of their pain, and thus, might be 
suffering in silence which in some cases may even lead to increased, unnecessary death rates 
[85,104]. 
Given the challenges highlighted above, exploring the manner by which individuals with 
CI process, experience and respond to pain is an imperative ethical goal. Moreover, such 
research is essential for the improved assessment and treatment of pain and to reduce 
unnecessary suffering. In recent years, several clinical studies have been conducted to assess 
and analyse pain responses in individuals with CI (for review see [1,29,50,75,84]). However, 
clinical studies are limited due to the fact that the stimuli that elicit the pain cannot be 
controlled nor measured. Experimental pain studies provide several advantages over clinical 
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studies. They allow for control of experimental stimulation, experimental interventions and 
measurement techniques by using standardized stimuli of different modalities often with 
widely available devices. Thus, experimental studies enable one to disentangle the stimuli 
from the nociceptive response, to carefully analyze stimulus-response relationships of painful 
events, to probe various sensory pathways and to study associations between pathological 
alterations and their functional consequences.  
Experimental studies use various stimulation modalities to induce pain, including thermal, 
mechanical, electrical and chemical stimuli of various frequencies, durations and intensities 
that can be applied to various body parts [5]. The methods applied to assess pain sensation 
range from measuring pain threshold (i.e. the minimal stimulation energy needed to induce 
pain) and pain tolerance, to measuring pain intensity and unpleasantness (i.e. the sensory vs. 
affective aspect) using rating-scales and behavioural scales. Various stimuli also are often 
applied in order to measure the evoked motor, autonomic, endocrine and brain responses. 
Depending on the methods used, different aspects of afferent and efferent nociceptive 
processes as well as different aspects of the multidimensional pain experience are 
investigated. Each measurement method can investigate only a limited fraction of the entire 
pain experience and thus, it is advisable to examine the impact of CI on pain processing using 
different experimental protocols.  
The aim of the present review is to summarize, for the first time, the current state-of-the- 
art knowledge on experimental pain responses among individuals with CI. Additional novel 
features of this review are the inclusion of studies employing animal models of CI as well as 
the inclusion of different types of CI having diverse underlying pathologies and diverse brain 
dysfunctions. Given the broad network of brain areas involved in pain processing (e.g. 
thalamus, somatosensory cortices (S1 and S2), caudate/putamen, cerebellum, and insular 
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cingulate, prefrontal and supplementary motor cortices) [4], and the variability between CI 
types in brain pathologies, the effects of CI on pain processing can vary greatly. 
 This review is intended to make a critical contribution: 1) by increasing the awareness of 
the possible alterations in pain perception and processing among individuals with CI, 2) by 
exploring how CI effects pain pathways in their ascending and descending parts, 3) by 
identifying common features of pain processing in CI regardless of etiology that can provide 
an empirical foundation for developing new tools for the identification and diagnosis of pain 
in this population and 4) by promoting better pain management in different types of CI 
subjects. For the purpose of this review we searched computerized databases (Pubmed, 
Medline, Scopus and Web of Science), published bibliographies of related topics, and 
references provided by colleagues. We limited our review to publications in the years 1960-
2014. We reviewed in-depth studies that collected sufficient data for meaningful statistical 
analysis and had a meticulous study design. The review is based on the best evidence 
available and on the opinion of a panel of experts (the authors) in cases of limited published 
data on certain topics. 
2. Aging and mild cognitive decline 
2.1. Age-related changes in pain processing 
Introduction: Even though healthy ageing is, by definition, characterized by a lack of CI, 
we decided to include ageing in this review for two reasons. First, mild cognitive decline has 
been repeatedly shown even in healthy ageing. Secondly, most of the pathological conditions 
in which CI is a major feature, are age-related (e.g. dementia). Therefore, there is a need to 
disentangle age-related changes from specific pathological changes that involve CI and have 
an effect on pain processing. So far, numerous studies have focused separately on age-related 
changes in pain or on age-related changes in cognition, however, rather little is known about 
the linkage between these two factors. Aging has consistently been associated with mild 
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overall cerebral atrophy as well as with a mild decline in various cognitive domains. Albeit 
within normal limits, the most pronounced affected functions include executive functions, 
episodic memory and psychomotor speed [28]. Several of these functions may already decline 
as early as the age of 25, with a steeper decline starting from the sixth decade of life [28].  
Pain measurements: A substantial number of studies have used experimental designs to 
study age-related changes in pain processing. Most often, the effect of ageing on pain has 
been investigated by assessing pain thresholds in elderly individuals. It has been found that 
age often leads to elevated pain thresholds when pain is applied using electrical current and 
heat, whereas pain thresholds for pressure can be decreased in elderly individuals [73]. There 
is also evidence for a decrease in pain tolerance with age. In line with the reduced pain 
tolerance are findings of reduced efficacy of conditioned pain modulation (CPM) along with 
increased temporal summation [73]. It is noteworthy that motivational and other perceptual 
aspects may confound measurements, especially that of tolerance as well as verbal reports of 
pain. Evidence for reduced functioning of the endogenous pain modulatory mechanism with 
aging can also be found in brain imaging studies, with older individuals showing lower striatal 
activity in response to pain compared to younger individuals, which might indicate 
dysfunctions in pain inhibitory circuits [25]. Based on these findings, age seems to impair 
ascending as well as descending pain pathways, however, with the latter being more severely 
affected by ageing [73]. And given this decline in descending pain inhibitory pathways, 
ageing seems to make the individual more vulnerable to suffering from pain, which is in line 
with clinical findings of increased pain prevalence in the elderly. 
As stated above, although numerous studies have focused on age-related changes in pain 
or in cognition, little is known about the linkage between the two areas. A question therefore 
remains whether age-related changes in cognition have an effect on pain processing. It has 
been shown that pain does have an impact on cognitive functioning, with severe pain 
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substantially impairing cognitive functioning [88]. Thus, it is possible that chronic pain in 
elderly patients contributes to age-related decline in cognition. With regard to the opposite 
direction, namely on how age-related changes in cognition affect the processing and 
perception of pain, very little is known. One recently conducted study [6] showed that 
reduced cognitive flexibility and memory capacities significantly predicted the development 
of chronic pain. Thus, there seems to be a vicious circle for elderly individuals, with pain 
leading to a decline in cognitive functioning and the decline in cognitive functioning leading 
to greater pain vulnerability. 
Conclusions and Recommendations for future studies: Ageing is accompanied by 
changes in pain processing that seem to render the elderly more vulnerable to suffering from 
pain. Moreover, ageing is accompanied by slight decreases in cognitive performances. There 
is evidence that the age-related increase in pain vulnerability and the age-related decline in 
cognition might not be independent symptoms but serve to amplify each other in the elderly. 
However, this evidence is very sparse and more studies are needed that aim to disentangle 
age-related changes from cognitive-related changes in pain processing in the elderly.  
2.2. Mild cognitive impairment 
Introduction: The concept of Mild Cognitive Impairment (MCI) refers to a group of 
changes interposed between the cognitive changes of normal ageing and what might 
constitute the changes seen in a very early dementia state [97,98] with a preserved autonomy 
on activities of daily living (ADL) and instrumental activities of daily living (IADL). MCI 
may induce not only memory and executive dysfunction but also visuospatial disturbances 
and emotional alterations including apathy and depression [97]. As research on MCI has 
advanced, it has become apparent that several clinical subtypes of MCI exist (e.g. amnestic 
MCI and non-amnestic MCI [97,98]), with multiple etiologies or causes for each subtype. For 
example, as far as presumed degenerative etiology is concerned, the amnestic MCI subtypes 
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would likely represent a prodromal form of Alzheimer's disease. Thus, brain pathologies and 
affected brain areas might differ between each MCI subtype and thus, the effect of MCI on 
pain processing might also differ depending on the specific subtype. 
Pain measurements: Only one study has investigated the impact of age and MCI on the 
pain response system [67]. The subjects (MCI subtypes were not assessed) were tested for 
their self-report, motor (RIII reflex), facial (Facial Action Coding System) and autonomic 
responses (galvanic skin response and heart rate) to noxious electrical stimulation of the sural 
nerve. Regression analyses revealed that cognitive status (within the group of MCI) was a 
significant predictor of the decrease in autonomic responsiveness to noxious stimulation. 
However, the self-report of pain, the RIII reflex threshold, heart rate responses, as well as 
facial responses to electrical pain stimuli were not altered in MCI patients compared to 
healthy controls of the same advanced age. 
Conclusions and Recommendations for future studies: Based on the small amount of 
empirical evidence available, pain processing seems to be largely unaffected in MCI. 
However, in order to arrive at a valid conclusion, larger scale longitudinal studies are needed 
that also differentiate between the varying pathologies underlying MCI.  
3. Neurodegenerative disorders 
3.1. Alzheimer’s disease  
Introduction: Alzheimer’s disease (AD) is the most frequent cause of dementia and is 
responsible for approximately 60% of dementia cases in the elderly [80]. AD leads to memory 
impairment (especially short-term), aphasia, reduced insight and other cognitive symptoms. 
The pathological changes in AD patients develop over decades and affect first the 
transenthorinal cortex and the hippocampus region. The changes then spread throughout the 
limbic system and, coinciding with diagnosis, there are widespread changes with interruption 
of connections between components of the limbic systems (equivalent to Braak stage IV to V) 
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[18,91] leading to emotional disorders such as anxiety and depression and in some cases even 
psychotic symptoms [108].  However, it appears that the sensory cortex is largely unaffected 
until the disease becomes very severe. The brain regions that are affected by AD overlap to a 
certain degree with those involved in pain processing [107], which has led to the hypothesis 
that pain processing and thus, the pain experience, is altered in AD. Besides alterations in the 
experience of pain, the cognitive decline might additionally affect the communication of pain.  
Interestingly, studies investigating the capacity of patients with dementia to comprehend or 
complete standard pain assessment scales (like the visual analogue scale (VAS) have 
repeatedly shown that this ability declines dramatically across the course of dementia [59,95]. 
In line with this, epidemiological studies have described a reduced report of pain [1,57]. 
Therefore, it is challenging to disentangle the effect that AD has on the ability to provide self-
report of pain from the effect it has on the processing of pain itself.  
Pain measurements: The hypothesis that AD leads to a change in pain processing has 
been studied in a number of experimental studies using a variety of pain induction methods 
(electrical, mechanical, heat stimuli) and using methods that are dependent on reaction time 
(method of limits) as well as independent of reaction time (staircase method). The findings are 
summarized in table 1. Seven psychophysical studies investigated pain thresholds (based on 
self-report) in AD patients. Five studies found no differences in threshold levels 
[11,13,44,58,78], whereas two studies found increased thresholds [24,26] compared with age 
matched controls. So far, four studies have investigated pain ratings of supra-threshold 
stimuli, of which three found no difference in pain ratings [24,58,66,] and one [101] found 
lower pain ratings to suprathreshold stimuli compared with controls. Pain tolerance (based on 
self-report) has only been investigated in two studies. One study showed increased tolerance 
in patients with AD compared with controls, using both ischemic and electrical stimuli [13]. 
The other study however, reported decreased pain tolerance using pressure stimuli in patients 
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with AD but no difference from controls in pain tolerance using the cold pressor test [58]. 
These contradictory findings cannot be explained simply by the different pain induction 
methods used because different outcomes were observed even when the same method was 
used (e.g. phasic pressure pain) [24,78]. It is possible that other methodological differences 
between studies as well as differences across studies in the severity of patients' dementia 
underlie the discrepant findings. It is also possible that the experimental pain assessment 
methods utilized are not appropriate tools in patients with AD. Patients with AD have 
impairment of short term memory and may have difficulties understanding instructions. 
Consequently, some of the differences may be due to the unintentional use of methods that 
may not be appropriate for patients with AD. 
Given the decline in cognitive capacities, it might be more appropriate, when assessing the 
impact of AD on pain processing, to assess pain responses which do not rely on the patients’ 
ability to give a self-report of pain. Along these lines, several studies of AD patients have 
assessed motor, autonomic, facial and brain responses to experimentally induced pain. These 
studies seem to present more consistent outcomes in that the majority of findings point to an 
augmented responsiveness to noxious stimuli in patients with AD and in patients with other 
forms of dementia. More precisely, most studies found that patients with dementia (mostly 
AD patients) show increased facial responses to pain [49,66,68] compared to healthy 
individuals; or at least a tendency for increased facial responses [78]. Importantly, this 
increase was not accompanied by an overall increase in facial responsiveness (e.g. unspecific 
grimacing) but was solely due to an augmentation of pain-specific facial expressions. 
Moreover, the threshold for the nociceptive flexion reflex (RIII) was significantly decreased in 
AD, thus, also pointing to an increase in pain processing which might manifest already at the 
spinal level [66].  Other studies have focused on brain responses. Despite the hypothesis of 
impaired pain pathway in AD, functional magnetic resonance imaging (fMRI) studies showed 
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that brain activity in response to noxious stimulation is preserved and even elevated in both 
the medial and lateral pathways [24,26]. Interestingly, these studies also observed prolonged 
activation in the pain pathways and increased activity in cognitive regions, such as the 
dorsolateral prefrontal cortex (DLPFC). This suggests that, in AD, the cognitive integration of 
pain may be altered. A study from Gibson et al. [44] that used evoked related potentials 
(ERPs) as an index of brain activation,  found no difference in peak amplitude in AD patients. 
However, in an earlier study from Yamamoto et al. [123], that included a mixed population of 
dementia cases, the authors failed to induce pain-evoked potentials in the subgroup of patients 
with severe dementia. It is therefore possible, that brain responses to noxious stimulation are 
increased in early and moderate stages of dementia and might decline in later stages. Due to 
ethical considerations, however, it is difficult to apply experimental pain induction procedures 
in patients suffering from more severe stages of dementia. The investigation of autonomic 
responses to pain has shown a decline in responsiveness in patients with dementia [66,101].  
The results of studies examining autonomic functions in AD have been conflicting, but 
several studies have found a dysfunction of autonomic responses that might be caused by AD-
related deficits in central cholinergic function [39]. Given that AD may be associated with 
autonomic dysfunction, the autonomic response might not be a valid pain indicator in this 
patient group.  
One study investigated placebo effects on venipuncture-induced pain in patients with AD 
and found that newly diagnosed patients (Mini Mental State Examination (MMSE) mean 24 ± 
1.22) were able to obtain a placebo effect of a similar magnitude as healthy age-matched 
controls. One year later, however, when the connectivity between the prefrontal lobes and the 
rest of the brain was reduced, the patients were no longer able to obtain a placebo effect [10]. 
Subsequent studies have supported the notion that a loss of prefrontal control is related to a 
loss of the placebo effect [12].  Losing the ability to obtain placebo effects could mean that 
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AD patients might need a higher dose of analgesic medications to achieve pain relief [10]. 
However, since AD patients are more frail and therefore more susceptible to adverse events 
[3] analgesic treatment should be carefully monitored.  
Conclusions and Recommendations for future studies: Although the empirical findings 
on pain processing in patients with AD are partially contradictory, the majority of findings 
seem to suggest that the processing/experience of pain is not diminished in patients with mild 
to moderate forms of dementia but - in contrary - the pain experience might even be elevated 
when considering certain types of pain responses (e.g. brain activity, facial responses). 
Whether this is also the case in late stages of AD should be investigated. Given the 
progressive cognitive decline in patients with AD, research on pain processing in this patient 
group should not rely solely on self-report ratings (since these become less valid) but instead 
use a multi-method approach (assessing verbal-reports, facial, neural, autonomic and motor 
responses). This is  especially important when investigating patients who are in the later 
stages of the disease. Moreover, the few studies on placebo effects and adverse events suggest 
that careful consideration of the pharmacological treatment of AD patients is warranted. 
3.2. Other types of neurodegenerative disorders 
Introduction: “Neurodegenerative disorders” is an umbrella term for disorders that are 
characterized by a progressive loss of neurons or of neural functioning. Besides Alzheimer´s 
disease (AD), neurodegenerative disorders include – amongst others - Amyotrophic Lateral 
Sclerosis (ALS), Multiple sclerosis (MS), Parkinson’s disease (PD), Frontotemporal dementia 
(FTD), Huntington’s disease (HD) and Lewy body dementia. The neurodegenerative 
processes that underlie this group of disorders also affect the cognitive functioning of the 
patients, although depending on the type of pathology, the CI ranges from only mild (e.g. 
ALS) to more severe impairments (FTD). In addition, patients may also present with motor 
disability, emotional disturbances such as depression and psychosis, as well as sleep 
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difficulties, autonomic failures and various pain syndromes [23, 48]. So far, only a few 
studies have investigated pain processing among patients with neurodegenerative disorders 
other than AD. Below, we will review the findings on FTD, PD, HD and MS. 
Pain measurements: 
Frontotemporal dementia (FTD): The experimental evidence on pain processing in 
patients with FTD is sparse. The one study that has been conducted in this patient group found 
that pain threshold and pain tolerance levels were increased in FTD patients compared to age-
matched healthy controls [20]. In line with this experimental finding of decreased pain 
sensitivity, caregivers reported a loss of pain awareness in FTD patients compared to patients 
with other dementia types [8]. It is possible that due to the fronto-temporal degeneration, 
cognitive–evaluative and motivational-affective aspects as well as memory for pain, and 
autonomic–neuroendocrine responses to pain, are prone to deterioration in FTD and thus, 
patients might indeed be suffering less from pain [107]. However, the degree to which pain 
sensitivity decreases in FTD might depend on the type of FTD; given that for the subtype 
“semantic dementia” care-givers have reported heightened pain sensation [111]. Experimental 
studies are needed to confirm these possible differences in pain sensitivity between different 
types of FTD. 
Parkinson’s disease (PD): Cognitive decline has often been reported in PD with 
approximately 30% of the patients having mild cognitive impairments and 30% having 
cognitive impairments already in the dementia range [79]. PD seems to render patients more 
sensitive to pain, with decreased pain and reflex thresholds [42,89,100]; however,  studies 
investigating nociceptive evoked brain potentials have produced inconsistent findings  [117].  
Interestingly, dopaminergic therapy seems effective in reducing this increased pain 
sensitivity, with pain thresholds and various responses to experimental pain stimuli being 
more comparable to healthy individuals during the "on" phase (periods when the 
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dopaminergic medication is working and motor symptoms are controlled) [117]. Furthermore, 
a CPM-study suggested that endogenous pain inhibition remains intact in PD patients [89]. It 
is important, however, to mention that the aforementioned studies did not report whether the 
patients with PD showed any signs of CI. Therefore, the interaction between PD, CI and pain 
is yet to be unravelled. 
Huntington’s disease (HD): Besides unwanted choreatic movements, behavioural and 
psychiatric disturbances, CI is one of the core symptoms in patients with HD. Few data are 
available on pain processing in HD. In patients with HD, increased pain- and RIII reflex 
thresholds were found (which suggest a decreased sensitivity to pain) [106] and are in line 
with the clinical observation that these patients do not complain about pain [96]. Moreover, 
laser evoked potentials (laser stimuli of noxious intensities) were also changed in HD, with 
increased latencies and decreased amplitudes [31]. Thus, self-report ratings, motor reflexes, 
and cortical responses all suggest a decrease in pain sensation in patients with HD. However, 
none of the studies have tried to relate these changes in pain sensation to the degree of CI. 
Multiple sclerosis (MS): Prevalence estimates of CI in MS range from 40% to 65% and 
cognitive deterioration tends to progress over time. In patients with MS the widespread 
lesions in the brain and spinal cord and the accompanying motor dysfunction result in various 
chronic pain syndromes including peripheral and central neuropathic pain, musculoskeletal 
pain and functional pain syndromes [118]. Only a few studies, however, assessed pain 
processing among patients with MS. These studies have found increased sensitivity to 
pressure-pain as well as inconsistent (either hyper- or hyposensitivity) but common sensory 
alterations in thermal and tactile sensitivity (e.g. [40,113]. Here again, these studies did not 
report whether the patients with MS showed any signs of CI and therefore, the interaction 
between MS, CI and pain is yet to be unravelled.  
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Conclusions and recommendations for future studies: Different types of 
neurodegenerative disorders (which affect cognitive performance) seem to have very different 
effects on the pain response system. Whereas pain responses are decreased in FTD and HD, 
they are amplified in PD. Clearly, more information on the perception of pain among 
individuals with neurodegenerative disorders is needed. Since such disorders vary with regard 
to the brain structures involved, it is necessary to understand the differential effects these 
pathologies have on the pain system. Furthermore, some pathologies may affect similar brain 
structures but might have differential effects (possibly due to different mechanisms at the 
molecular level). For example, although both PD and HD affect the functioning of the basal 
ganglia, the impact that these two pathologies have on pain processing seem to be opposing 
(as is their effect on motor responses), with PD being accompanied by increased pain 
sensitivity whereas HD seems to decrease pain sensitivity.  
4. Developmental disability 
Introduction: Developmental disability is a broad term used for “a diverse group of severe 
chronic conditions that are due to mental and/or physical impairments, which include autism, 
cerebral palsy and intellectual disability”.  Autism Spectrum Disorders (ASDs) are 
characterized by impairment in the social interaction and communication domain, restricted 
repetitive and stereotyped patterns of behaviour, interests, and activities, and/or abnormal 
functioning. Autism has a strong genetic basis although environmental factors have also been 
suggested to interact with its underlying mechanism. Cerebral Palsy is a group of movement, 
muscle tone and/or posture disorders that are often accompanied by disturbances of sensation, 
perception, cognition, communication and behaviour. Cerebral Palsy is caused by abnormal 
development of, or damage to motor control centres of the brain. Intellectual disability (ID) 
(previously termed mental retardation) is characterized by impairments of general mental 
abilities that affect adaptive functioning in the conceptual, social and practical domains. 
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Individuals with ID have a limited ability to learn, reason, make decisions and solve 
problems. ID, which is the most common developmental disability [83] may be related to 
infections, chromosomal abnormalities, environmental, metabolic or nutritional causes, toxic 
insults and trauma before and after birth [109].  
There is great diversity among individuals with developmental disability with respect to 
many factors and specifically, in the presence and/or the degree of CI. For example, Asperger 
syndrome, one of the ASDs, lacks delays in cognitive development. The percentage of 
individuals with autism who also meet criteria for CI varies greatly, from 25% to 70%, 
pointing to the difficulty in assessing CI in this population. Nevertheless, most individuals 
with autism have mild CI [124]. The prevalence of CI among individuals with cerebral palsy 
ranges between 23 and 44% [93] and can vary from mild to profound. With regard to ID, 
about 85% of individuals with ID have mild CI and the proportion of individuals with 
moderate, severe and profound ID is 10, 4 and 1%, respectively.  
Recent structural imaging studies revealed alterations in brain anatomy among individuals 
with developmental disability. For example, in individuals with autism, neuronal loss in the 
cerebellum, brainstem, parietal and frontal cortex as well as in the limbic system such as 
reduced amygdala and dentate gyrus volume have been reported [74]. In children with 
cerebral palsy and CI, white matter lesions throughout the brain, including but not limited to 
regions associated with the sensorimotor system, ventricular dilatation (affecting circuits in 
the periventricular regions) and thinning of the posterior corpus callosum are common [36]. 
Similarly, in individuals with ID, abnormalities within the periventricular white matter, lateral 
ventricular dilatation, corpus callosum thinning, and decrease in white matter volume in the 
insula, cingulate, amygdala, frontal lobes, thalamus, brain stem (extending to pons), parietal 
sensory-motor tracts, and fronto-cortical circuits [53,122,126] have been reported. Such 
pathologies may underlie not only the aforementioned cognitive dysfunctions but also the 
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psychiatric and psychological problems (e.g. obsessive compulsive disorders and emotion 
dysregulation) that are present in some cases [62].  
Most of the aforementioned structures are involved in the processing of the sensory as 
well as the affective-motivational aspects of pain. Therefore, alterations in these structures 
may be associated with alterations in the processing of painful events among individuals with 
developmental disability.  
Pain measurements: Up until recently, the commonly held view was that individuals with 
developmental disability have decreased sensitivity to pain [e.g. 14,38]. This view was based 
on the tendency of these individuals not to report pain in potentially harmful situations, and 
from the difficulty of assessing pain in these individuals due to their poor communication 
capabilities. Observations of self-injurious behaviour amongst some individuals with 
developmental disability have also contributed to this view.  
Only a few studies of persons with ID have actually measured sensitivity to pain, i.e. pain 
threshold. These studies are summarized in Table 2. In the first study of its kind, pain 
threshold were assessed in individuals with Down’s syndrome (DS) by measuring the time 
elapsed from the application of an ice cube to the first verbal expression of pain [54]. The 
onset of pain response was longer in individuals with DS compared with controls suggesting a 
higher pain threshold in the former. However, as this method includes a reaction time artefact 
(i.e. the time it takes the individual to respond verbally to the sensation evoked by the ice 
cube), the threshold was confounded by this artefact. Defrin and co-workers [32] measured 
pain threshold among individuals with ID with the reaction-time inclusive method of limits 
(subjects are required to press a switch upon pain detection) and the reaction-time free method 
of levels (subjects report post factum whether a pre-determined stimulus was painful or not). 
Individuals with ID had a similar pain threshold to that of controls when measured with the 
method of limits but a significantly lower pain threshold compared to controls when measured 
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with the method of levels. It was concluded that slower reaction time renders the pain 
threshold higher when measured with the method of limits but not the method of levels, and in 
fact, individuals with ID have increased pain sensitivity compared to normal contrary to the 
previously held view [32].  
More recent studies have measured pain threshold with the method of limits among 
various populations of developmental disability. Adults with high functioning autism had 
lower pain thresholds compared to controls [21]. Likewise, children (but not adults) with 
cerebral palsy [103] were found to be more sensitive to pain compared to controls. In contrast, 
adolescents with Prader-Willi syndrome (a neuro-genetic developmental disorder with a 
tendency to self-injury) had increased pain thresholds compared to controls [99].  
With regard to facial expressions of pain, we found only two studies in which facial 
expressions were analysed following four innocuous stimuli (heat, cold, pressure and touch) 
and one presumably noxious stimulus (pin prick) among adults with severe and profound ID 
[110,114]. Simons and co-workers found similar increases in facial activity following all of 
these stimuli compared to baseline (Table 2) with no differences between responses to 
innocuous and noxious stimuli. However, given that pinprick was applied using a Neuropen, 
and that the stimuli were not tested among controls, there is no assurance that pinprick was 
perceived by the subjects as painful. To the best of our knowledge, autonomic responses to 
experimental pain stimuli were not measured among individuals with developmental 
disability. There is evidence, however, that individuals with ID present elevated heart rate 
during venepuncture compared to unimpaired individuals [102] suggesting that evaluation of 
objective responses to experimental pain among these individuals is called for.  
Conclusions and recommendations for future studies: On the basis of the majority of 
existing findings we may conclude that individuals with developmental disability are more 
sensitive to pain than control subjects. This finding corresponds with imaging studies showing 
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damage to structures involved in pain modulation, i.e. the brain stem and frontal cortex as 
well as structures involved in pain processing (e.g. cingulate, insula and sensory cortex). Still, 
some inconsistency exists in pain threshold among the different impairment types. This 
inconsistency could reflect differences in pain processing between developmental disability 
syndromes despite seemingly similar structural alterations in the brain. Alterations in 
peripheral and/or central conduction of sensory signals may also be responsible for variations 
in the sensitivity to pain, especially if pain threshold is measured with methods that include 
reaction time. While such alterations have been reported for innocuous stimuli [19,99] studies 
are needed to test whether such alterations occur in nociceptive pathways. Due to the 
possibility of delayed reaction time, measuring pain threshold with methods that bypass this 
limitation, i.e. reaction-time free methods, is preferable. However, pain threshold 
measurement is suitable primarily for individuals with mild and perhaps for some individuals 
with moderate cognitive impairment. Thus, the use of indirect indices of pain is necessary. 
Although behavioural indices of pain such as facial expressions were mostly analysed in the 
clinical setting, additional studies are needed in order to explore which indices best reflect 
pain in the various types of developmental disability.  
5. Cognitive impairment secondary to vascular and traumatic insults 
Introduction: CI is a frequent outcome after vascular or traumatic insults to the brain. The 
degree of CI, however, can vary largely between only slight impairments (e.g. after mild 
traumatic brain injuries) to extreme impairments (e.g. after severe brain damage as in patients 
in vegetative state). Vascular and traumatic insults to the brain can alter pain processing 
directly by affecting ascending and descending nociceptive pathways, and indirectly, by 
affecting cognitive and emotional pathways. The two possibilities may also exist 
simultaneously.  
5.1. Stroke 
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Stroke and cerebral small vessel disease is a common cause of CI and the most common 
pathology underlying vascular dementia. Connections between areas of the cortex associated 
with complex information processing are disrupted thus, leading to impaired cognition and 
function, motor disability, psychological or emotional impairments and in some cases 
communication disorders such as aphasia. Fatigue and chronic pain are also common after 
stroke [86]. The most frequent types of pain after stroke are hemiplegic shoulder pain, central 
post-stroke pain and post-stroke headache [9,65]. Thus, stroke seems to render the patient 
more vulnerable to pain. Several studies have investigated the mechanism underlying the 
development of pain after stroke and found alterations in pain processing, surprisingly 
manifested in increased pain thresholds [e.g. 63,125]. However, to the best of our knowledge, 
in none of these studies were patients with CI included and therefore the specific effects of CI 
on pain processing among stroke patients are unknown. 
5.2. Traumatic brain injury 
Traumatic brain injury (TBI) can cause long term CI (attention, memory, and executive 
functioning) in addition to changes in personality, disturbances of mood and emotion 
regulation, the degree of which depends on the extent, location and severity of TBI. Chronic 
pain is frequent after TBI. The most frequent type of pain after TBI is chronic post traumatic 
headache, followed by central pain, musculoskeletal pain and peripheral neuropathic pain 
[90,116]. Thus, like stroke, TBI seems to render patients more vulnerable to pain. Indeed, 
when using experimental pain, it was found that TBI patients showed heightened pain 
sensitivity as indicated by decreased pressure pain threshold, hyper excitability in the painful 
regions and reduced pain habituation and modulation compared to controls [33,34,94]. 
However, these studies did not include patients with known CI and therefore the specific 
effects of CI on pain processing among TBI patients are yet to be discovered. 
5.3. Vegetative state and minimal conscious state 
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Many individuals who acquire severe brain injury experience prolonged disorders of 
consciousness. Persons in a vegetative state (VS) differ from persons in a minimal conscious 
state (MCS) for the absence of discernible, even if inconsistent, awareness of self or 
environment [43]. The diagnosis of VS and MCS is usually based on clinical judgment. In 
recent years however, the results of neuroimaging [16] and neurophysiological studies [22] 
and studies of technology-based learning set-ups have been a supplement to the diagnosis 
[69]. By showing that arousal reaction toward multimodal and especially painful stimuli may 
be present even in vegetative state, these studies have fundamentally changed the way one 
thinks about these conditions. A controversial issue in the management of patients in a 
vegetative or a minimally conscious state concerns their hypothetical capacity to continue to 
experience pain despite an apparent absence of self- and environmental awareness. Thus, 
recently clinical, functional and neuroimaging studies have been conducted in order to address 
this important concern. 
Pain measurements: Recent functional neuroimaging studies have shown a greater 
responsiveness to pain in patients in MCS compared with patients in vegetative state. Using 
PET imaging, electrical noxious stimulation activated similar regions of the thalamus, primary 
and secondary somatosensory cortices and the frontoparietal and anterior cingulate cortex in 
patients in MCS and in healthy controls [16]. Activity in these areas - known as the ‘pain 
matrix’- was markedly greater in patients in MCS than in patients in VS, who show no 
evidence of self or environmental awareness. Furthermore, VS patients only showed activity 
in the primary somatosensory but not the associative cortex following electrical stimulation 
[72]. However, the findings of these two studies are limited by the use of electrical stimuli 
which are not specific to nociceptive processing and thus may activate a cortical network 
devoted to salient stimuli rather than noxious stimuli. In another study where  O15–H2O PET  
was employed to explore the responsiveness of VS patients to painful electrical stimuli, 
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Kassubeck et al [60] observed posterior insula/secondary somatosensory cortex (SII), post-
central gyrus/primary somatosensory cortex (SI) and cingulate cortex activation during 
stimulation which was perceived as noxious in controls. In a recent study, laser evoked 
responses, which are a specific tool to explore pain pathways, were present among patients in 
MCS and VS, albeit with prolonged latencies [30]. Interestingly, the cortical responses to 
electrical stimuli, delivered at an intensity which was perceived as painful in controls,   were 
absent in most of the VS and MCS patients. Importantly, electrical stimuli primarily activate 
A-beta fibres although activation of nociceptive fibers is possible depending on stimulation 
intensity. However, given the relatively high activation threshold of nociceptive pathways in 
VS and MCS patients, the employment of laser stimuli which specifically activate A-delta and 
C afferents, seems more appropriate to test pain related reactions in such patients.  
Conclusions and recommendation for future studies: The use of cerebral functional 
studies is changing our opinion about the possible absence of pain sensation and reaction in 
patients with severe brain damage (MCS and even VS). Several studies have found cortical 
responses to painful stimuli even in VS patients. This suggests that even after severe brain 
damage, cortical areas are activated for a potential response against dangerous environmental 
factors. Functional studies employing stimuli that specifically activate nociceptive pathways , 
such as laser stimuli, are needed to confirm the cortical arousal of severe brain damaged 
patients and to identify the response to noxious stimuli as a condition of minimal cortical 
preservation. 
6. Translational studies: what can we learn from animal models of cognitive 
impairment?  
Introduction: The homology of basic biological processes such as 'nociception' among 
animals and humans has rendered animals - mostly rodents - a relevant tool in basic and 
preclinical pain research [52]. In addition, modelling of psychiatric and neurological diseases 
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in animals by means of classical neuropsychopharmacological approaches, spontaneous 
mutants or the most recent molecular biology engineered models has provided new 
opportunities to study pain comorbidity [17]. However, so far only a limited number of 
experimental studies have examined pain in animal models of CI or dementia [45]. 
 In the absence of the equivalence to self-reports, nociception tests must rely on 
observable behaviours that range from a simple nocifensive withdrawal reflex to complex 
operant behaviours. Thus, some tests measure the latency of the avoidance behaviour in 
response to thermal (e.g. tail-flick test, hot-plate test), mechanical (e.g. von Frey test, paw 
pressure test), chemical (e.g. formalin test) or electrical stimuli, as an indicator of the 
sensitivity of the animal to stimuli. Others record spontaneously emitted behaviours following 
noxious stimulation (e.g. abnormal gait or hunched posture) or operant behaviours (e.g. 
learned escape or place aversion). Changes induced by pain in cognitive (e.g. attention), 
emotional (e.g. freezing), physical (e.g. changes in body weight) and social behaviours (e.g. 
aggression) are also considered important as pain-related correlates [87]. Interestingly, 
behavioural responses such as facial expression and vocalizations – which are the focus in 
observational pain rating scales for patients with dementia - are starting to be considered and 
have been successfully translated to non-human animals [70,112,51,120]. 
CI in animal models is usually evaluated with behavioral tests for the assessment of 
learning and memory and spatial orientation or place navigation. The Morris water maze for 
example, a circular maze filled with opaque water, in which a rodent searches for an escape 
platform hidden under the water surface, is probably the most widely used test of spatial 
learning and memory. This maze is believed to evaluate deficits in hippocampal-related 
behaviors that can be found in models of Alzheimer's disease [47]. Since deficits in gating 
functions and signal processing are also found in neuropsychiatric disorders, sensorimotor 
gating tests such as the prepulse inhibition (PPI) of the startle reflex elicited by a strong 
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sensory stimulus, are also common [119]. Additional behavioral approaches are used to study 
executive function in rodents, especially working memory and cognitive flexibility, which are 
sensitive to decline with age across species and for which well validated rodent models 
currently exist (for review see [15]. 
Pain measurements: What has been found with regard to pain processing in the different 
animal-models of cognitive impairment? Are these findings in line with the findings in human 
subjects? Table 3 addresses these questions by providing broaden overview on the main 
outcomes for human and animal models of different types of CI. The Table summarizes 
studies addressing face validity (features),  predictive validity (outcome of interventions), and 
construct validity (neurological basis). Age-related cognitive decline in C57BL/6J mice is 
characterized by impairment of motor skills, acquisition and memory consolidation, yet in 
contrast to findings in human subjects, the mice show well-preserved noxious threshold and 
working memory [37].  
Mild cognitive impairment (MCI) is difficult to model in animals except when it is 
regarded as the transitional state preceding AD. In such a case, MCI is studied as the 
prodromal stage that follows the premorbid period and precedes the moderate and advanced 
stages of AD disease. Mutations of amyloid precursor protein (APP) and presenilins (PS) 1 
and 2, associated with amyloid deposition, brain structural change and cognitive decline, are 
used to emulate AD in transgenic animals but different models may present with different 
results regarding nocifensive responses and variations may also exists within a model 
depending on the stimulation modality. For example, the sensitivity to cold stimuli is 
unaltered in 3xTg-AD mice that progressively develop both beta-amyloid and tau in cortical 
and limbic areas [46]. Responses of the old mutants in the hot-plate test were also unaltered 
[41]. However, the avoidance response latency in the tail flick test was increased in an age-
dependent manner equally to its background C57BL/6 strain [7]. Other models for AD such as 
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the double mutant TASTPM mice expressing human APP(695(K595N, M596L)) x 
PS1(M146V ) also show differential responsiveness: lower sensitivity in the hot water tail-
flick test but increased sensitivity in the hot-plate test [27]. As inconsistencies in responses to 
pain exist also among patients with AD, these models show the important role of key 
neurobiological hallmarks of the disease and help to depict their contribution in the 
derangement of the neuronal pathways related to pain.   
  There are very few well-characterized animal models for FTD. One of these models is 
the progranuline [PGRN]-deficient mouse based in the loss-of-function mutations of PGRN as 
the cause of familial ubiquitin-positive FTD. These mice show progressive neuropathology, 
signs of premature aging and behavioural deficits [76]. They are currently used to study pain 
defence after nerve injury as well as the development or maintenance of neuropathic pain. 
Much more common in experimental use is the partial trisomic Ts(1716)65Dn mice (Ts65Dn) 
based on genetic homology to model Down’s syndrome, the most common genetic cause of 
developmental disability in humans. The Ts65Dn mice show reduced thermal sensitivity 
threshold in the tail-flick test but normal sensitivity to morphine assessed in this test as 
compared to control littermates [82]. Furthermore, Ts65Dn mice display the expected 
biphasic (early and late) behavioural response in the formalin test but with reduced sensitivity. 
It is uncertain if the reduced sensitivity is due to diminished peripheral nociceptor 
responsiveness and/or less effective central processing of nociceptive signals [35,92]. It is 
noteworthy that these results are similar to those of two studies showing increased pain 
threshold among individuals with Down’s syndrome when measured with a reaction-time 
inclusive method [32,54]. The double transgenic APP/SOD1 mouse model of Down 
syndrome shows reduced sensitivity for neuropathic pain associated with neuroma and a 
decreased autotomy response [64]. The murine model for fragile X mental retardation 1, the 
FMR1 knock-out mice, shows normal acute responses to noxious stimuli assessed in the hot 
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plate and tail-flick [61,127]. In the rat valproic acid (VPA) model of autism, adolescent rats 
prenatally exposed to VPA exhibited hypoalgesia on the hot plate test [61] supporting reports 
of altered pain sensitivity among individuals with autism.   
Conclusions and recommendation for future studies: Although important advances have 
been achieved in recent years using animal models of CI, a few limitations should be 
considered regarding their use. First, although executive functions can be demonstrated in 
various animals, they are substantially more developed and, as a consequence, more 
vulnerable to impairment in humans. Second, the relatively short length of the ‘aging’ 
processes in rodents may not mimic time-dependent neuronal modifications involved in 
nociceptive processing among elderly patients. However, large animals, mostly those whose 
pain is naturally developed over time such as cats and dogs [55], are proposed as better 
models to study pain in aged-related CI. This is also the case for the ‘Cognitive Dysfunction 
Syndrome’, a naturally developed neurodegenerative disease characterized in cats and dogs 
that is also considered a model of Alzheimer’s disease [71]. Third, despite the fact that 
mammals have a high degree of neuroanatomical similarity to humans (as opposed to non-
mammalian models), they are generally expensive and time-consuming to use. Fourth, the 
concerns about the poor predictive validity of experimental pain for chronic pain conditions 
that is applied to studies of experimental pain in humans can also be applied to animal 
models. 
Certainly, further studies of pain in naturally occurring or induced animal models of 
cognitive impairment and dementia are required.  Nevertheless, at present, studies of 
transgenic rodents harbouring the human familial AD mutations that closely mimic the 
temporal, neuroanatomical and behavioural patterns of the human disease offer great 
advantages due to their shorter time requirements, lower maintenance expenses and ethical 
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considerations. These models are especially promising for the development of new treatments 
for AD and other age-related cognitive impairments. 
7. Overall conclusions 
CI is a frequent consequence of many neurological diseases, of neurodegenerative 
changes and of vascular and traumatic insults to the brain. CI also may gradually appear in the 
course of healthy ageing. The literature on the experimental analyses of effects of CI on pain 
processing is sparse. Nevertheless, existing data suggest that pain processing is frequently 
altered compared to cognitively intact matched controls. There seems to be no common 
denominator for all types of CI reviewed herein, with regard to the nature of this alteration. 
Rather, variability exists across different types of CI, with increased or decreased pain 
threshold and pain tolerance and decreased or lack of change in pain ratings (see Table 3). 
Obviously, this variability may stem from structural variability in the brain regions affected 
by each condition and the extent of the damage as well as of the functional consequences and 
their counter-regulation. Variability may also stem from between-studies differences in the 
experimental protocol and the severity as well as exact type of CI within the sample tested.  
To date, studies of pain processing in animal models of cognitive impairment and 
dementia have been sparse. As can be seen in Table 3, some of the findings derived from 
animal models are in agreement with findings in CI patients, whereas others point in a 
different direction. Novel developments in animal research that make use of non-verbal 
behaviours like facial expressions, seem promising approaches that allow assessment of 
similar behaviours in human and animals and thus, can help to better translate findings from 
animal to human research. 
Importantly, because studies in individuals with CI in general, and in individuals who 
cannot report their pain in particular, are uniquely challenging, it is critical that researchers 
adhere to the declaration of Helsinki and conduct the studies in the most empathic, 
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compassionate and ethically sound manner possible. It is also important that researchers have 
sufficient experience in pain assessment and that all testing protocols would first be tested 
among healthy volunteers and adjusted prior to testing individuals with CI. In the search for 
additional knowledge that can help future patients, one must carefully consider all risks and 
benefits and keep in mind the interests and vulnerability of the patients at hand. 
Despite the diversity between CI types, it appears that those with widespread brain 
atrophy or neural degeneration (ageing, MCI, Alzheimer’s disease, traumatic brain injuries, 
multiple sclerosis, autisms, cerebral palsy) all show increased pain responses and/or greater 
pain sensitivity. We can only speculate that the widespread brain damages, especially those 
involving white matter, affect descending pain modulation pathways which in turn lead to 
reduced inhibitory control over the pain system. It is possible that these descending pain 
modulation pathways are more susceptible to such damage whereas ascending pathways are - 
in comparison - more robust. In cases of severe brain damage that is associated with severe  
CI such as in patients in VS and MCS, both the ascending and descending pain pathways 
might be disrupted to a similar degree resulting perhaps in reduced sensitivity to pain.  Neural 
atrophies restricted to regions associated with processing of ascending nociceptive input, such 
as in patients with FTD, may also render patients less sensitive to pain. Regardless of the 
etiology of CI, however, the scientific evidence suggests that the majority of patients do seem 
to feel noxious stimuli. Thus, despite the communication difficulties characteristic of CI 
rendering pain assessment a challenge in this population, true changes in pain processing have 
to be assumed. Therefore, and in light of the high rates of chronic pain, special attention 
should be drawn to careful and dedicated pain monitoring and management in those with CI.  
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 Table 1: Overview of the number of studies finding an increase, decrease or no changes in pain responses among patients with dementia 
 Self-report Other pain responses 
 Pain threshold 
 Dependent on 
reaction time 
Independent of 
reaction time 
Tolerance 
threshold 
Supra-threshold 
pain ratings 
Brain 
activation 
Facial expression 
Pain 
reflexes 
Autonomic 
responses 
Increase  
 
 
2 
[ref. 24,26] 
1 
[ref. 13] 
 
2 
[ref. 24,26] 
3 
[ref. 49+,66*,68*] 
1 
[ref. 66*] 
 
Decrease  
 
  
1 
[ref. 58] 
1 
[ref. 101] 
1 
[ref. 123*] 
  
2 
[ref. 66*,101] 
No Change 
 
1 
[ref. 58] 
5 
 [ref. 11,13,44,58,78] 
1 
[ref. 58] 
3 
[ref. 24,58,66*] 
1 
[ref. 44] 
1 
[ref. 78] 
  
Unmarked referencese relate to studies patients with Alzheimer's disease (AD).  
*references refer to studies on both AD patients and mixed forms of dementia 
+ 
references refer to studies on patients with dementia of unknown origin 
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Table 2: Overview of the number of studies finding an increase, decrease or no changes in pain responses among individuals with 
developmental disabilities 
 Self-report Other pain responses 
 Pain threshold 
 Dependent on 
reaction time 
Independent of 
reaction time 
Facial expression 
Autonomic 
responses 
Increase 
 
2 
[ref. 54,99] 
 
2 
[ref. 110,114*] 
1 
[ref. 102] 
Decrease  
 
2 
[ref. 21,103] 
1 
[ref. 32] 
  
No Change 
 
1 
[ref. 32] 
   
Populations tested: Downs' syndrome (ref. 27,42), autism spectrum disorder (ref. 18,83), cerebral palsy 
(ref. 84), Prader-Willi syndrome (ref. 81), non specified intellectual disability (ref. 27,90,93). 
*comparison to own baseline
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Table 3: “Rough” estimation of the impact of different types of cognitive impairment on pain processing in humans and animals 
Human Studies Animal Models - Translational studies 
Type of cognitive 
impairment 
Degree of cognitive 
impairment 
Amount of 
experimental 
evidence 
Pain sensitivity (overall 
tendency based on  
experimental evidence) 
Type of animal model Pain sensitivity 
Mild cognitive 
impairment 
mild Sparse Unchanged 3xTg-AD mice Unchanged 
Alzheimer's disease Mild to severe Substantial Unchanged or increased 3xTg-AD mice 
 
TASTPM 
Unchanged 
 
Increased as well as 
decreased 
Frontotemporal dementia Mild to severe Sparse Decreased Progranuline [PGRN]-
deficient mouse 
Under investigation 
Parkinsons' disease Mild to severe Sparse 
 
Mostly increased - - 
Huntingtons' disease Mild to severe Sparse Decreased 
 
- - 
Individuals with 
developmental disability 
Mild to severe Moderate Unchanged,  increased 
or decreased 
TrisomicTs(1716)65Dn 
mice (Ts65Dn) 
& 
APP/SOD1 mice of 
Down Syndrome 
 
FMR1 knock-out mice 
Decreased 
 
 
 
 
 
Unchanged 
Minimal conscious state/ 
vegetative state 
Severe Sparse Unchanged or decreased 
(but not completely 
abolished) 
 
- - 
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